Jared Aron compares how fast the US and UK actually adopt healthcare innovation, and makes the case that a real human phone call still beats an AI voice agent at the moment that matters most.
“We had several patients upon being contacted that said, 'is this a person?' And the answer was of course, yes. And they couldn't believe it.”— Jared Aron
Jared Aron contrasts the pace of healthcare innovation in the US, where a large commercial market and clinical leaders comfortable with commerciality drive fast adoption, against the UK, where a legacy of national provision makes even private clinics slower to adopt new tools. He points to specific vendors doing it well: Third Way Health's end-to-end model, Voca's early work in agentic communication, and medical scribes as one of the first AI categories clinicians have actually embraced at scale.
He draws a sharp line between where AI already works and where it doesn't. AI scribes succeed because they operate inside a clinical, contextually bound workflow; voice AI receptionists are a much harder problem because the valuable part of a patient call isn't answering it, it's a uniquely human discovery conversation. He tells a story of patients responding to a real human call with disbelief, asking outright 'is this a person?' — proof of how rare and valuable that moment has become.
Pushed for his single hottest take, Jared names the UK's cultural discomfort with commerciality as the real innovation blocker. Then, asked how he'd spend a hypothetical £100k clinic budget, he says he would rebuild the entire front-of-house function rather than buy new equipment or spend more on marketing, arguing that most clinics are already leaking value they haven't optimized before chasing anything new.
Coherent gives private clinics one patient relationship engine, recovering revenue lost at enquiry, recall and billing.